Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases

INTRODUCTION: Obesity has been associated with adverse disease-related outcomes and inferior treatment response to biologic agents in patients with inflammatory bowel diseases (IBDs), but its impact on the risk of treatment-related complications is unknown. We performed a cohort study examining the...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Siddharth, Heien, Herbert C., Sangaralingham, Lindsey, Shah, Nilay D., Sandborn, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260899/
https://www.ncbi.nlm.nih.gov/pubmed/34228004
http://dx.doi.org/10.14309/ctg.0000000000000380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260899/
https://www.ncbi.nlm.nih.gov/pubmed/34228004
http://dx.doi.org/10.14309/ctg.0000000000000380

Ejemplares similares